These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27548881)

  • 1. The potential of toxin-based drug delivery systems for enhanced nucleic acid therapeutic delivery.
    Shorter SA; Gollings AS; Gorringe-Pattrick MAM; Coakley JE; Dyer PDR; Richardson SCW
    Expert Opin Drug Deliv; 2017 May; 14(5):685-696. PubMed ID: 27548881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disarmed anthrax toxin delivers antisense oligonucleotides and siRNA with high efficiency and low toxicity.
    Dyer PDR; Shepherd TR; Gollings AS; Shorter SA; Gorringe-Pattrick MAM; Tang CK; Cattoz BN; Baillie L; Griffiths PC; Richardson SCW
    J Control Release; 2015 Dec; 220(Pt A):316-328. PubMed ID: 26546271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationic polymer based nanocarriers for delivery of therapeutic nucleic acids.
    Nimesh S; Gupta N; Chandra R
    J Biomed Nanotechnol; 2011 Aug; 7(4):504-20. PubMed ID: 21870455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MATra - Magnet Assisted Transfection: combining nanotechnology and magnetic forces to improve intracellular delivery of nucleic acids.
    Bertram J
    Curr Pharm Biotechnol; 2006 Aug; 7(4):277-85. PubMed ID: 16918404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexity in the therapeutic delivery of RNAi medicines: an analytical challenge.
    Colombo S; Zeng X; Ragelle H; Foged C
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1481-95. PubMed ID: 24950005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-viral nucleic acid containing nanoparticles as cancer therapeutics.
    Kozielski KL; Rui Y; Green JJ
    Expert Opin Drug Deliv; 2016 Oct; 13(10):1475-87. PubMed ID: 27248202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of amphoteric curdlan derivatives for delivery of therapeutic nucleic acids.
    Tong Y; Ganbold T; Baigude H
    Carbohydr Polym; 2017 Nov; 175():739-745. PubMed ID: 28917924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of a Novel Liposomal DDS by Manipulating Pharmacokinetics and Intracellular Trafficking for Drug Therapy and Nucleic Acid Medicine].
    Hatakeyama H
    Yakugaku Zasshi; 2018; 138(5):591-598. PubMed ID: 29709998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration.
    de Wolf HK; Snel CJ; Verbaan FJ; Schiffelers RM; Hennink WE; Storm G
    Int J Pharm; 2007 Mar; 331(2):167-75. PubMed ID: 17134859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
    Kim HK; Davaa E; Myung CS; Park JS
    Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular delivery of siRNA and antisense oligonucleotides via receptor-mediated endocytosis.
    Ming X
    Expert Opin Drug Deliv; 2011 Apr; 8(4):435-49. PubMed ID: 21381985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide spiders are emerging as novel therapeutic interventions for nucleic acid delivery.
    Rahman M; Sahoo A; Almalki WH; Almujri SS; Altamimi ASA; Alhamyani A; Akhter S
    Drug Discov Today; 2024 Jul; 29(7):104021. PubMed ID: 38750928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent in vivo advances in cell-penetrating peptide-assisted drug delivery.
    Kurrikoff K; Gestin M; Langel Ü
    Expert Opin Drug Deliv; 2016; 13(3):373-87. PubMed ID: 26634750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.
    Xu L; Anchordoquy T
    J Pharm Sci; 2011 Jan; 100(1):38-52. PubMed ID: 20575003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
    Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H
    J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel environment-sensitive biodegradable polydisulfide with protonatable pendants for nucleic acid delivery.
    Wang XL; Jensen R; Lu ZR
    J Control Release; 2007 Jul; 120(3):250-8. PubMed ID: 17582638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How cationic lipids transfer nucleic acids into cells and across cellular membranes: recent advances.
    Rehman Zu; Zuhorn IS; Hoekstra D
    J Control Release; 2013 Feb; 166(1):46-56. PubMed ID: 23266451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in nucleic acid delivery with polyethylenimines.
    Neuberg P; Kichler A
    Adv Genet; 2014; 88():263-88. PubMed ID: 25409609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-viral Delivery Systems for Breast Cancer Gene Therapy.
    Vaseghi G; Rafiee L; Javanmard SH
    Curr Gene Ther; 2017; 17(2):147-153. PubMed ID: 28595562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in non-viral nucleic acids delivery.
    Salem AK; Patil SD; Burgess DJ
    Int J Pharm; 2012 May; 427(1):1-2. PubMed ID: 22143087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.